Publication | Closed Access

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Diabetes ManagementCardiovascular DiseaseDiabetesPharmacologyCardiovascular PharmacologyType 2Pioglitazone Versus SulfonylureasPharmacotherapyDiabetes MellitusMedicineAtherosclerosisCardiovascular Events